Drug information for SYNAREL

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
SPRAY, METERED; NASAL	EQ 0.2MG BASE/SPRAY	Prescription	(Reference Drug)	NAFARELIN ACETATE	Nafarelin	GD SEARLE LLC	19886 2012-01-17 Letter 2012-01-12 Label 2011-01-11 Label 2011-01-11 Label 2011-01-07 Letter 2011-01-07 Letter 2006-04-13 Label 2006-04-13 Letter 1999-07-21 Review 1998-12-24 Letter

Drug Adverse Effects information for SYNAREL

Role code	Indications	Reaction	# Reports
PS	ENDOMETRIOSIS	BONE LOSS	1
PS	ENDOMETRIOSIS	MULTIPLE FRACTURES	1
PS	ENDOMETRIOSIS	OSTEOPOROSIS	1
SS	PRODUCT USED FOR UNKNOWN INDICATION	MALAISE	3

Ads by Google